Article History
First Online: 9 June 2021
Competing interests
: A.M.P. has received research funding from an educational grant from Sanofi Genzyme and Novo Nordisk. J.B.B. has received research support from Amgen; has served as a consultant and/or on advisory boards for Amgen, Dova, Novartis, Rigel, UCB, Momenta–Johnson & Johnson, Argenix, Principia-Sanofi, RallyBIo and Regeneron; and was a member of the Data Safety Monitoring Board for UCB, CSL Behring. D.B.C. has received research support from Syntimmune/Attenuon and served as a consultant and/or on advisory boards for Novartis, Johnson & Johnson, Dova, Tavanta and Rigel.
Free to read: This content has been made available to all.